IBIO, INC. Conversion of Stock, Shares Converted
IBIO, INC. (IBIO) reported Conversion of Stock, Shares Converted of 2.22 thousand shares for the 12-month period ending 2019-06-30, per its 10-K filed 2019-08-26.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesConverted1 · last filed 2019-08-26
- IBIO, INC. conversion of stock, shares converted for the quarter ending 2019-06-30 was 405.00 shares.
- IBIO, INC. conversion of stock, shares converted for the quarter ending 2019-03-31 was 561.00 shares.
- IBIO, INC. conversion of stock, shares converted for the quarter ending 2018-12-31 was 450.00 shares.
- IBIO, INC. conversion of stock, shares converted for the quarter ending 2018-09-30 was 807.00 shares.
- IBIO, INC. conversion of stock, shares converted for fiscal 2019 was 2.22K shares, a 2370.00% increase from fiscal 2018.
- IBIO, INC. conversion of stock, shares converted for fiscal 2018 was 90.00 shares.
| Period end | Conversion of Stock, Shares Converted 1 month | Conversion of Stock, Shares Converted 2 month | Conversion of Stock, Shares Converted 2 month as first filed | Conversion of Stock, Shares Converted 3 month | Conversion of Stock, Shares Converted 6 month | Conversion of Stock, Shares Converted 9 month | Conversion of Stock, Shares Converted 12 month |
|---|---|---|---|---|---|---|---|
| 2019-06-30 | 405.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-26 | 966.00 shares derived: sum of 2 quarters · filed 2019-08-26 | 1.42K shares derived: sum of 3 quarters · filed 2019-08-26 | 2.22K shares 10-K · filed 2019-08-26 | |||
| 2019-03-31 | 561.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-10 | 1.01K shares derived: sum of 2 quarters · filed 2019-05-10 | 1.82K shares 10-Q · filed 2019-05-10 | ||||
| 2018-12-31 | 450.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-13 | 1.26K shares 10-Q · filed 2019-02-13 | |||||
| 2018-09-30 | 807.00 shares 10-Q · filed 2018-11-13 | ||||||
| 2018-08-31 | 6.30K shares 10-Q · filed 2019-02-13 | 672.00 shares 10-K · filed 2018-09-18 | |||||
| 2018-06-30 | 90.00 shares 10-K · filed 2018-09-18 | 90.00 shares 10-K · filed 2019-08-26 | |||||
| 2018-06-26 | 6.30K shares 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |